Form 4: Boston Scientific Director Zane Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director Ellen M. Zane sold 13,586 shares of Boston Scientific (BSX) common stock at an average price of $104.2348 under a pre-established Rule 10b5-1 trading plan.
Summary
- On February 24, 2025, Ellen M. Zane, a director of Boston Scientific Corp (BSX), sold 13,586 shares of common stock.
- The sale was executed at a weighted average price of $104.2348 per share.
- The transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on November 14, 2024.
- Following the transaction, Zane directly owns 34,944 shares of Boston Scientific common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-established trading plan and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Sales by insiders are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific inside information at the time of the transaction.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 02/24/2025 | Date of the transaction (sale of shares) |
Keywords
Boston Scientific, BSX, Ellen M. Zane, Director, Share Sale, Form 4, 10b5-1 Trading Plan, Securities Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.